Journal Information
Vol. 40. Issue 1.
Pages 18-25 (January - February 2016)
Vol. 40. Issue 1.
Pages 18-25 (January - February 2016)
DOI: 10.1016/j.medine.2015.01.002
Full text access
Epidemiology and prognostic factors in severe sepsis/septic shock. Evolution over six years
Epidemiología y factores pronósticos de la sepsis grave/shock séptico. Seis años de evolución
I. Azkárate
Corresponding author

Corresponding author.
, G. Choperena, E. Salas, R. Sebastián, G. Lara, I. Elósegui, L. Barrutia, I. Eguibar, R. Salaberria
Servicio de Medicina Intensiva, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, Spain
Article information
Full Text
Download PDF
Figures (5)
Show moreShow less
Tables (5)
Table 1. Clinical characteristics of the patients admitted to the ICU due to severe sepsis/septic shock.
Table 2. Organ dysfunction and gender of the patients admitted to the ICU due to severe sepsis/septic shock.
Table 3. Comparative analysis of the quantitative variables in relation to mortality.
Table 4. Comparative analysis of the qualitative variables in relation to mortality.
Table 5. Multivariate analysis of the variables associated to mortality.
Show moreShow less

To determine the clinical characteristics and prognostic factors of patients with severe sepsis/septic shock admitted to the Intensive Care Unit of Donostia University Hospital (Guipuzcoa, Spain).


A prospective, observational study was carried out during a consecutive 6-year period (1st February 2008–31st December 2013).


The Intensive Care Unit of Donostia University Hospital, the only third level hospital in the province of Guipuzcoa, with a recruitment population of 700,000 inhabitants.


Number of patients with severe sepsis/septic shock has progressively increased over the last years to reach 1136 patients, yet significant changes in age, sex, Acute Physiology and Chronic Health Evaluation II, procalcitonin and lactate values could not be observed. In the last years, admission rate from Emergency Department has increased in comparison to admissions from hospitalization ward, with a higher incidence of urological sepsis. Hemodynamic and renal dysfunctions have been the most prevalent disorders, respiratory involvement and thrombocytopenia have gone down while coagulopathy has increased significantly. Mortality has decreased significantly. We have performed a multivariate analysis of the early prognostic factors. Type, origin, sepsis etiology, lactate and the presence of organ dysfunction–except for hyperbilirubinemia and hypotension–were the most important mortality factors.


Severe sepsis and septic shock result in growing ICU admissions. Although clinical features have barely changed over the last years, we have observed a decrease in mortality. We find important knowing these early prognostic factors to improve the management of these patients.

Severe sepsis
Septic shock
Early prognostic factors

Examinar las características clínicas y los factores pronósticos de los pacientes ingresados por sepsis grave/shock séptico en la Unidad de Cuidados Intensivos del Hospital Universitario Donostia.


Estudio observacional prospectivo durante un período consecutivo de 6 años (1-2-2008 a 31-12-2013).


Servicio de Medicina Intensiva del Hospital Universitario Donostia, único hospital terciario de Guipúzcoa.


El número de pacientes con sepsis grave/shock séptico ha aumentado progresivamente hasta un total de 1.136, sin observarse cambios significativos en la edad, el sexo, la puntuación del Acute Physiology and Chronic Health Evaluation II, los valores de procalcitonina ni en los de lactato sérico. En los últimos años ha habido un aumento significativo de los ingresos desde Urgencias respecto a los procedentes de planta, con una mayor incidencia de la sepsis urológica. La afectación hemodinámica y renal han sido las disfunciones más prevalentes, descendiendo la afectación respiratoria y la trombocitopenia y aumentando la coagulopatía. La mortalidad ha descendido significativamente. Mediante un análisis multivariante analizamos factores pronósticos precoces: el tipo de paciente, su procedencia, la etiología de la sepsis, la cifra de lactato y la presencia de disfunciones orgánicas, exceptuando la hiperbilirrubinemia y la hipotensión, fueron las variables más influyentes en la mortalidad.


La sepsis grave/shock séptico genera un creciente número de ingresos. A pesar de que las características clínicas han variado poco en los últimos años, hemos observado un descenso de la mortalidad. Consideramos importante el conocimiento de los factores pronósticos precoces para mejorar el abordaje de estos pacientes.

Palabras clave:
Sepsis grave
Shock séptico
Factores pronósticos precoces
Full Text

Sepsis results in important morbidity and mortality, particularly when associated to organ dysfunction and/or shock. The Surviving Sepsis Campaign was launched in the year 2002 with the aim of reducing the mortality of sepsis through the development and introduction of clinical practice guides, published for the first time in 20041 and last revised in 2012.2 Different studies have shown that adherence to these guides,3,4 and particularly early antibiotic administration, improves patient survival.5 In Spain, the Edusepsis study6,7 made it possible to know the clinical characteristics and epidemiological data of these patients in our country, and demonstrated that the application of an educational program is able to increase compliance with the treatment “bundles” and lessen mortality in severe sepsis/septic shock (SeS/SSh). The ABISS-Edusepsis study was subsequently carried out (with results pending publication) with the purpose of evaluating a multiple intervention for improving early empirical antibiotic treatment in sepsis, with the aim of reducing patient mortality.

In our case, participation in both of the mentioned studies allowed us to develop a registry and conduct educational campaigns in our center and in the different district hospitals that refer patients to our hospital. Through data collection over these 6 years, we aimed to determine the existence of possible variations in the characteristics and evolution of these patients, and to identify early prognostic factors capable of helping us to improve their clinical management.

Material and methods

A prospective observational study was made over a 6-year period (from 1 January 2008 to 31 December 2013) in the Intensive Care Unit (ICU) of Donostia University Hospital (San Sebastián, Spain). Our Unit belongs to a third-level hospital and has 48 beds, with a total recruitment population of 700,000 inhabitants.

We included all patients who upon admission to or during their stay in the ICU presented SeS/SSh according to the definitions of the International Sepsis Conference of 2001.8 In all cases follow-up was carried out until hospital discharge.

Study variables:

  • -

    Demographic data: patient age, gender and origin.

  • -

    Patient type and origin of sepsis.

  • -

    Data on the severity of the condition: Acute Physiology and Chronic Health Evaluation II (APACHE II score) (in all patients, except those who died in the first 24h), organ dysfunction secondary to sepsis, presence or absence of hypoglycemia, procalcitonin peak (100ng/ml being the maximum value offered by the laboratory), and lactate in the first 6h of sepsis onset or of admission to the ICU.

  • -

    Patient management data: lactate measurement request, extraction for blood cultures, and administration of antibiotics (previous and upon admission to the ICU).

  • -

    In-ICU and global (ICU+hospital) mortality.

With regard to determination of the prognostic factors, we analyzed all the variables corresponding to the first 12h of sepsis onset, excluding the patients admitted before June 2008, since the procalcitonin values were not available for these individuals.

Statistical analysis

Quantitative variables were expressed as the mean and standard deviation, while qualitative variables were reported as absolute numbers and percentages. The comparison of means was made using the Student t-test or analysis of variance (ANOVA), while the comparison of proportions was carried out using the chi-squared test. With regard to evolution over the 6-year period, when the comparison of means using ANOVA yielded statistically significant differences, we applied an increasing or decreasing linear trend test with a one-way procedure through polynomial sub-instruction=2. When the comparison of proportions with the chi-squared test proved significant, we checked whether the proportions showed an increasing or decreasing trend by means of the Mantel–Haenszel linear trend test. Statistical significance was considered for p<0.05. The SPSS® version 20 statistical package was used throughout.

The multivariate analysis was carried out with construction of the logistic regression model adopting the stepwise-backwards strategy, and including those variables which in the univariate analysis yielded p<0.30, as well as the relevant control variables with good theoretical justification. Calibration of the model was made using the Hosmer–Lemeshow goodness of fit test. The validity of the logistic regression model was estimated by calculating the area under the curve with a 95% confidence interval (95%CI).


In the last 6 years we have observed a gradual increase in the number of patients with sepsis admitted to our Unit (Table 1). In total, 1136 patients presented SeS/SSh upon admission or during the course of stay in the ICU. Some of the clinical characteristics were seen to remain stable, with no significant differences in mean age (between 62 and 65 years), gender (with a clear male predominance), the Acute Physiology and Chronic Health Evaluation II scores (between 20 and 22), procalcitonin concentration (between 33 and 37ng/ml) or arterial lactate levels in the first 6h (between 25 and 31mg/dl). Regarding organ dysfunction (Table 2), hemodynamic and renal alterations were the most prevalent problems during this period. A significant decreasing trend was observed in relation to respiratory problems and thrombocytopenia, with an increasing trend in the case of coagulopathy. The percentage of patients with hyperbilirubinemia remained without significant variations.

Table 1.

Clinical characteristics of the patients admitted to the ICU due to severe sepsis/septic shock.

  2008  2009  2010  2011  2012  2013  p 
Patients, n  153  181  177  198  218  209   
Mean age (years)  62 (13.6)  63 (13.60)  64 (13.71)  63 (13.99)  65 (13.27)  65 (14.17)  NS 
APACHE II score  20.5 (6.86)  22 (8.09)  20.5 (7.51)  21 (7.41)  20 (6.79)  20 (7.27)  NS 
Procalcitonin (ng/ml)  36 (34.08)  33 (34.84)  33 (34.43)  34 (35.71)  36 (36.06)  37 (34.07)  NS 
Lactate 6h (mg/dl)  28 (19.47)  29 (24.50)  25 (17.22)  29 (23.04)  31 (29.41)  28 (20.48)  NS 

APACHE II: Acute Physiology Score and Chronic Health Evaluation II. The results are reported as the mean (standard deviation).

Table 2.

Organ dysfunction and gender of the patients admitted to the ICU due to severe sepsis/septic shock.

  2008  2009  2010  2011  2012  2013  p 
Organ dysfunction (%)
Hypotension  91.5  96  88  93  94  93  NS 
Renal involvement  65  70  70  71  74  69  NS 
Thrombocytopenia  43  33  30  28  31  29  0.04 
Respiratory involvement  59  64  49  49  54  48  0.010 
Coagulopathy  46  38  36  56  49  47  0.001 
Hyperbilirubinemia  25  21  18  20  22  22  NS 
Gender (%)
Males  70  66  64  66  65  60  NS 

During the first three years, the patients were admitted mainly from hospital wards, though in the last years there has been a significant increase in admissions from emergency care (Fig. 1). Likewise, there have been significant increases in lactate measurement requests, extractions for blood cultures, and the administration of antibiotics prior to admission to the ICU (Fig. 2). Regarding the origin of the disease (Fig. 3), sepsis of respiratory and abdominal origin predominated in the course of the 6-year study period, followed by urinary tract infections, which have experienced an increase to the point of becoming the first cause of SeS/SSh in 2012. Mortality both in the ICU and globally in hospital has experienced a significant decrease (Fig. 4).

Figure 1.

Origin of the patients admitted due to severe sepsis/septic shock.

Figure 2.

Management of patients with severe sepsis/septic shock prior to admission to the ICU.

Figure 3.

Origin of sepsis in the patients admitted to the ICU due to severe sepsis/septic shock.

Figure 4.

Mortality in the ICU and globally in hospital in the patients admitted due to severe sepsis/septic shock.


As early predictors of mortality in the ICU, we only analyzed the variables present in the first 12h of sepsis onset. The univariate analysis (Tables 3 and 4) show the deceased patients to be significantly older and with significantly higher procalcitonin and lactate levels, as well as a larger percentage of organ disorders–with the exception of hypotension. Patient gender and the administration of antibiotics before admission to the ICU had no significant impact. The mortality rate among the patients admitted from hospital wards or who developed the condition in the ICU was greater than among those admitted directly from emergency care. Trauma patients showed greater mortality, followed by emergency surgery patients and medical patients. Elective surgery patients showed the best survival figures. With respect to the underlying etiology, sepsis of unknown origin involved the highest mortality, followed by intraabdominal infections, while sepsis of biliary or urinary origin showed better survival.

Table 3.

Comparative analysis of the quantitative variables in relation to mortality.

Condition at discharge from ICU  Mean value (SD)  p 
Age (years)
Survivors  833  63.7 (13.7)  0.03 
Deceased  183  66.11 (13.3)   
Procalcitonin (ng/ml)
Survivors  879  33.7 (34.2)  0.009 
Deceased  181  41.15 (38.2)   
Lactate 6h (mg/dl)
Survivors  749  24.65 (17.04)  <0.001 
Deceased  164  46.37 (36.0)   

SD: standard deviation; ICU: Intensive Care Unit.

Table 4.

Comparative analysis of the qualitative variables in relation to mortality.

  Survivors, n (%)  Deceased, n (%)  p 
Gender      0.8 
Males  566 (83.1)  115 (16.9)   
Females  317 (82.3)  68 (17.7)   
Patient type      0.001 
Medical  643 (84.7)  116 (15.3)   
Surgical (emergency)  130 (74.7)  44 (25.3)   
Surgical (elective)  96 (86.5)  15 (13.5)   
Trauma  14 (63.6)  8 (36.4)   
Patient origin      0.003 
Emergency care  395 (87.4)  57 (12.6)   
Donostia University Hospital ward  320 (80)  80 (20)   
Other hospital ward  107 (81.7)  24 (18.3)   
ICU  61 (73.5)  22 (26.5)   
Origin of sepsis      <0.001 
Pneumonia  219 (82.6)  46 (17.4)   
Urinary  174 (93)  13 (7.0)   
Biliary  88 (90.7)  9 (9.3)   
Intraabdominal  168 (74.3)  58 (25.7)   
Soft parts  69 (82.1)  15 (17.9)   
Others  112 (86.8)  17 (13.2)   
Not known  53 (67.9)  25 (32.1)   
Organ dysfunction
Respiratory      <0.001 
No  457 (92.0)  40 (8.0)   
Yes  426 (74.9)  143 (25.1)   
Renal      <0.001 
No  288 (90.9)  29 (9.1)   
Yes  595 (79.4)  154 (20.6)   
Coagulopathy      <0.001 
No  526 (90.1)  58 (9.9)   
Yes  357 (74.1)  125 (25.9)   
Thrombocytopenia      <0.001 
No  648 (88.3)  86 (11.7)   
Yes  235 (70.8)  97 (29.2)   
Hyperbilirubinemia      0.001 
No  708 (85.0)  125 (15.0)   
Yes  175 (75.1)  58 (24.9)   
Hypotension      0.07 
No  67 (89.3)  8 (10.7)   
Yes  816 (82.2)  175 (17.7)   
Hypoglycemia      <0.001 
No  818 (86.7)  126 (13.3)   
Yes  65 (53.3)  57 (46.7)   
Pre-ICU antibiotic treatment      0.163 
No  119 (78.8)  32 (21.2)   
Yes  764 (83.5)  151 (16.5)   

ICU: Intensive Care Unit.

The multivariate analysis (Table 5) found the variables significantly correlated to mortality to be the lactate levels, the presence of respiratory alterations, hypoglycemia, thrombocytopenia, coagulopathy and renal involvement, patient type and origin, and the origin of sepsis. Mortality was not conditioned by the presence of hypotension, hyperbilirubinemia, procalcitonin concentration, or patient age. The Hosmer–Lemeshow test revealed an excellent fit of the model (0.084, with an area under the curve [AUC] of 0.863 [95%CI 0.834–0.892; p<0.0001]) (Fig. 5).

Table 5.

Multivariate analysis of the variables associated to mortality.

  OR (95%CI)  p 
Organ dysfunction
Respiratory involvement  4.75 (2.83–7.98)  <0.001 
Renal involvement  2.06 (1.22–3.47)  0.007 
Coagulopathy  2.09 (1.34–3.27)  0.001 
Thrombocytopenia  2.74 (1.77–4.22)  <0.001 
Hypoglycemia  3.59 (2.01–6.4)  <0.001 
Patient origin    0.003 
Emergency care     
Donostia University Hospital ward  2.32 (1.38–3.88)  0.001 
Other hospital ward  1.68 (0.87–3.26)  0.125 
ICU  3.90 (1.63–9.29)  0.002 
Lactate 6h  1.03 (1.02–1.04)  <0.001 
Patient type
Elective surgery    0.033 
Medical  2.38 (1.05–5.41)  0.038 
Trauma  4.9 (1.41–16.98)  0.012 
Emergency surgery  2.72 (1.24–5.99)  0.013 
Origin of sepsis
Pneumonia    <0.001 
UTI  0.48 (0.2–1.16)  0.104 
Biliary  0.27 (0.09–0.83)  0.023 
Abdominal  2.56 (1.28–5.12)  0.008 
Soft parts  2.78 (1.18–6.60)  0.020 
Others  1.45 (0.66–3.20)  0.361 
Unknown  4.30 (1.97–9.42)  <0.001 

CI: confidence interval; ITU: urinary tract infection; OR: odds ratio. Results are expressed as odds ratio (95% confidence interval).

Figure 5.

Receiver operating characteristic (ROC) curve showing an area under the cure of 0.863.


Our registry shows that SeS/SSh generates an increasing number of admissions to the ICU, though the patient characteristics have changed little over these years. Findings such as the increasing trend in patients admitted directly from the emergency service, and the increase in requests for lactate determinations and blood cultures, as well as the growing tendency to administer antibiotics prior to admission to the ICU, suggest that the education campaigns in our province have contributed to improve the management of sepsis. As a result of these campaigns, we have established consensus on measures such as the use of noradrenalin as vasopressor treatment in the emergency services of all the district hospitals, which until the year 2012 lacked such treatment. In this way we are able to ensure earlier hemodynamic resuscitation, which may have contributed to the observed decrease in certain organ dysfunctions, such as thrombocytopenia and lung damage, and fundamentally to the decrease in patient mortality.

These data encourage us to intensify the educational campaigns and continue to register our clinical activity with a view to identifying opportunities for improvement. To this effect, and through the logistic regression analysis, we have attempted to identify early predictors of mortality due to sepsis. In this regard, mention must be made of the identification of arterial lactate concentration, which coincides with the findings of many other studies,9,10 where the magnitude of lactacidemia is seen to reflect the severity of hypoperfusion and is directly related to patient mortality. The same cannot be said of procalcitonin, for although this marker is clearly useful in diagnosing bacterial infections,11 its prognostic relevance is less clear.12 In our registry, the procalcitonin levels were not found to be related to mortality. However, it must be underscored that in all patients we recorded the peak value, not the clearance value–which according to some investigators13,14 could constitute a better prognostic marker.

Regarding organ dysfunction, its usefulness as a predictor of mortality has been firmly established.15,16 In our case there were two exceptions: hypotension and hyperbilirubinemia. Marchick et al.17 showed that the presence of hypotension–even when not sustained over time–in emergency care in septic patients increases mortality risk during hospital admission. In our registry, however, this was not found to be related to increased mortality. The explanation for this may be that hypotension could have acted as an alarm signal helping to recognize the severity of sepsis earlier, start resuscitation measures earlier, and accelerate admission to the ICU. On the other hand, the group of “hypotensive” patients is very heterogeneous and comprises both subjects requiring low-dose vasopressor treatment and rapid hemodynamic stabilization, and patients with refractory shock. The results might have been different on considering the severity and duration of hypotension. In this context, arterial lactate appears to be a more objective measure of severity.

The presence of hyperbilirubinemia in sepsis is often related to liver disorders, though cholestasis, circulating endotoxin and hemolysis may also cause hyperbilirubinemia. We found few literature references to its potential prognostic utility. In this regard, Zhai et al.18 reported a relationship between bilirubin elevation upon admission to the ICU and the development of adult respiratory distress syndrome and increased mortality. In our registry these patients did not show a poorer prognosis, possibly because an important number of them presented sepsis of biliary origin, which is associated to lesser mortality and could affect the global results.

In reference to organ dysfunction, it should be mentioned that hypoglycemia, while not considered a criterion of severe sepsis, has been shown to be related to mortality in many studies.19 We perform conventional, non-intensive, blood glucose monitoring with the aim of securing levels of ≤150mg/dl. As a result, the presence of hypoglycemia is rarely secondary to insulin therapy. Although the underlying etiology may be multifactorial,20 we consider it important to point out that hypoglycemia was secondary to severe liver dysfunction in a significant proportion of our patients–manifesting before hyperbilirubinemia and involving high mortality.

Other prognostic variables were the patient type, the origin of sepsis and the patient origin. In this regard, patients undergoing elective surgery showed greater survival, while trauma patients showed greater mortality–this coinciding with the observations of large both trauma21,22 and surgical registries.23 In our case, and in coincidence with Reyes et al.,24 sepsis of unknown origin was associated to increased mortality. In contrast, Zahar et al.25 considered that mortality is not influenced by the origin of sepsis but by the early and adequate start of antibiotherapy. Although this is a very relevant prognostic factor in the literature, our registry showed no differences between patients who had or had not received antibiotic treatment prior to admission to the ICU. This observation draws our attention, though a more in-depth analysis is probably required–in all cases examining the timing of administration from the onset of symptoms, and investigating whether the antibiotic used was adequate once the microbiological data became known. Since in many of our patients administration took place outside the hospital, we lack the data needed for such an analysis.

Lastly, those patients admitted to the ICU from the hospital ward and who developed sepsis once in the Unit showed significantly greater mortality. We consider that a number of factors influenced this situation, including the nosocomial nature of some infections,26 and delays in recognizing the disease–particularly among patients coming from hospital wards. We probably should intensify our educational efforts in the ward setting, with the introduction of organizational changes–creating multidisciplinary teams and a sepsis code, with a view to improving the management of these patients.

Our study has a number of limitations. On one hand, it is a single-center study, and although the sample size is quite large, the validity of the findings may have been affected as a result. On the other hand, since in many cases the management measures were started outside our hospital, we lack information on relevant aspects such as the timing of antibiotic administration and other initial measures recommended in the Surviving Sepsis Campaign.

In conclusion, it should be underscored that severe sepsis/septic shock is responsible for an increasing number of admissions to the ICU, with high morbidity-mortality. Through our clinical activity we have attempted to define the epidemiological characteristics of our patients and the prognostic factors involved, with a view to ensuring earlier identification and a better approach to the management of this disease. In this regard, we consider it important to continue the introduction of educational campaigns and to promote the creation of a sepsis code with the intervention of multidisciplinary teams.

Conflicts of interest

The authors declare that they have no conflicts of interest.

R.P. Dellinger, J.M. Carlet, H. Masur, H. Gerlach, T. Calandra, J. Cohen, et al.
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.
Intensive Care Med, 30 (2004), pp. 536-555
R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, S.M. Opal, et al.
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012.
Crit Care Med, 41 (2013), pp. 580-637
A. Castellanos-Ortega, B. Suberviola, L.A. García-Astudillo, M.S. Holanda, F. Ortiz, J. Llorca, et al.
Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study.
Crit Care Med, 38 (2010), pp. 1036-1043
R.R. Miller 3rd, L. Dong, C. Nelson, S.M. Brown, K.G. Kuttler, D.R. Probst, et al.
Multicenter implementation of severe sepsis and septic shock treatment bundle.
Am J Respir Crit Care Med, 188 (2013), pp. 77-82
A. Kumar, D. Roberts, K.E. Wood, B. Light, J.E. Parrillo, S. Sharma, et al.
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.
Crit Care Med, 34 (2006), pp. 1589-1596
R. Ferrer, A. Artigas, M.M. Levy, J. Blanco, G. González-Díaz, J. Garnacho-Montero, et al.
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain.
JAMA, 299 (2008), pp. 2294-2303
D. Suarez, R. Ferrer, A. Artigas, I. Azkarate, J. Garnacho-Montero, G. Gomà, et al.
Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain.
Intensive Care Med, 37 (2011), pp. 444-452
M.M. Levy, M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, D. Cook, et al.
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.
Crit Care Med, 31 (2003), pp. 1250-1256
M.E. Mikkelsen, A.N. Miltiades, D.F. Gaieski, M. Goyal, B.D. Fuchs, C.V. Shah, et al.
Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock.
Crit Care Med, 37 (2009), pp. 1670-1677
R.C. Arnold, N.I. Shapiro, A.E. Jones, C. Schorr, J. Pope, E. Casner, the Emergency Medicine Shock Research Network (EMShockNet) investigators, et al.
Multi-center study of early lactate clearance as a determinant of survival in patients with presumed sepsis.
Shock, 32 (2009), pp. 35-39
L. Simon, F. Gauvin, D.K. Amre, P. Saint-Louis, J. Lacroix.
Serum procalcitonin and C-reactive protein levels as markers of bacterial infections: a systematic review and meta-analysis.
Clin Infect Dis, 39 (2004), pp. 206-217
M.J. Ruiz-Alvarez, S. García-Valdecasas, R. de Pablo, M. Sánchez García, C. Coca, T.W. Groeneveld, et al.
Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis.
J Intensive Care Med, 24 (2009), pp. 63-71
R. Claeys, S. Vinken, H. Spapen, K. ver Elst, K. Decochez, L. Huyghens, et al.
Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates.
Crit Care Med, 30 (2002), pp. 757-762
J.C. Ruiz-Rodríguez, J. Caballero, A. Ruiz-Sanmartin, V.J. Ribas, M. Pérez, J.L. Bóveda, et al.
Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study.
Med Intensiva, 36 (2012), pp. 475-480
A.E. Jones, S. Trzeciak, J.A. Kline.
The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation.
Crit Care Med, 37 (2009), pp. 1649-1654
M.M. Levy, W.L. Macias, J.L. Vincent, J.A. Russell, E. Silva, B. Trzaskoma, et al.
Early changes in organ function predict eventual survival in severe sepsis.
Crit Care Med, 33 (2005), pp. 2194-2201
M.R. Marchick, J.A. Kline, A.E. Jones.
The significance of non-sustained hypotension in emergency department patients with sepsis.
Intensive Care Med, 35 (2009), pp. 1261-1264
R. Zhai, C.C. Sheu, M.N. Gong, P. Tejera, F. Chen, Z. Wang, et al.
Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis.
Thorax, 64 (2009), pp. 784-790
J. Hermanides, R.J. Bosman, T.M. Vriesendorp, R. Dotsch, F.R. Rosendaal, D.F. Zandstra, et al.
Hypoglycemia is associated with intensive care unit mortality.
Crit Care Med, 38 (2010), pp. 1430-1434
T.M. Vriesendorp, S. van Santen, J.H. DeVries, E. de Jonge, F.R. Rosendaal, M.J. Schultz, et al.
Predisposing factors for hypoglycemia in the intensive care unit.
Crit Care Med, 34 (2006), pp. 96-101
T.M. Osborn, J.K. Tracy, J.R. Dunne, M. Pasquale, L.M. Napolitano.
Epidemiology of sepsis in patients with traumatic injury.
Crit Care Med, 32 (2004), pp. 2234-2240
A. Wafaisade, R. Lefering, B. Bouillon, S.G. Sakka, O.C. Thamm, T. Paffrath, et al.
Epidemiology and risk factors of sepsis after multiple trauma: an analysis of 29,829 patients from the Trauma Registry of the German Society for Trauma Surgery.
Crit Care Med, 39 (2011), pp. 621-662
L.J. Moore, F.A. Moore, S.R. Todd, S.L. Jones, K.L. Turner, B.L. Bass.
Sepsis in general surgery: the 2005–2007 national surgical quality improvement program perspective.
Arch Surg, 145 (2010), pp. 695-700
W.J. Reyes, S. Brimioulle, J.L. Vincent.
Septic shock without documented infection: an uncommon entity with a high mortality.
Intensive Care Med, 25 (1999), pp. 1267-1270
J.R. Zahar, J.F. Timsit, M. Garrouste-Orgeas, A. Français, A. Vesin, A. Descorps-Declere, et al.
Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
Crit Care Med, 39 (2011), pp. 1886-1895
M. Pujol, E. Limón.
Epidemiología general de las infecciones nosocomiales. Sistemas y programas de vigilancia.
Enferm Infecc Microbiol Clin, 31 (2013), pp. 108-113

Please cite this article as: Azkárate I, Choperena G, Salas E, Sebastián R, Lara G, Elósegui I, et al. Epidemiología y factores pronósticos de la sepsis grave/shock séptico. Seis años de evolución. Med Intensiva. 2016;40:18–25.

Copyright © 2015. Elsevier España, S.L.U. and SEMICYUC
Medicina Intensiva (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.